Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof

Dov Zipori (Inventor), Yaron Shav-Tal (Inventor), Mira Barda-Saad (Inventor)

Research output: Patent

Abstract

Mesenchymal cells are unexpectedly found to express specific truncated versions of immunoglobulin (Ig) superfamily members, namely T cell receptors and related proteins of the immunoglobulin superfamily, as exemplified by the υ heavy chain. Mesenchymal T cell receptor and Ig heavy chain gene products either directly or indirectly control hemopoetic stem cells. Antisense therapy and antibodies can be used to reduce TCR and Ig heavy chain mediated functions. Conversely, overexpression of the TCR and/or Ig heavy chain can be used to induce hemopoesis, for example in stem cell transplantation or following chemotherapy.
Original languageAmerican English
Patent numberUS20040101931 A1
StatePublished - 2003

Fingerprint

Dive into the research topics of 'Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof'. Together they form a unique fingerprint.

Cite this